| P50 | author | Jennifer A Slyker | Q110385657 |
| P2860 | cites work | Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era | Q26781359 |
| | Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants | Q28077904 |
| | Seroprevalence of cytomegalovirus infection in the United States, 1988-1994 | Q28267544 |
| | Inflammatory and coagulation biomarkers and mortality in patients with HIV infection | Q28473903 |
| | Cytomegalovirus infection enhances the immune response to influenza. | Q30300254 |
| | Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. | Q30352064 |
| | Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants | Q33358114 |
| | Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas | Q33392372 |
| | Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts | Q33784189 |
| | Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis | Q33808573 |
| | Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. | Q51024710 |
| | Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. | Q51568906 |
| | Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans. | Q51994116 |
| | Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapy. | Q52600469 |
| | Cytomegalovirus in human milk. | Q53721409 |
| | Rapid detection and quantification of cell free cytomegalovirus by a high-speed centrifugation-based microculture assay: comparison to longitudinally analyzed viral DNA load and pp67 late transcript during lactation | Q54751280 |
| | Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. | Q54770469 |
| | Breast Milk and the Risk of Cytomegalovirus Infection | Q56431619 |
| | Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates | Q56797588 |
| | Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy | Q58473814 |
| | Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding | Q60029201 |
| | Cytomegalovirus-Specific CD4 and CD8 T Cell Responses in Infants and Children | Q63535571 |
| | Maternal cytomegalovirus excretion and perinatal infection | Q68661799 |
| | Increased rate of cytomegalovirus infection among parents of children attending day-care centers | Q70138716 |
| | Cytomegalovirus infection of breast milk and transmission in infancy | Q70160668 |
| | Specific Cell-Mediated Immunity and the Natural History of Congenital Infection with Cytomegalovirus | Q70180828 |
| | Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers | Q70202564 |
| | Rapid progression of HIV disease in children with cytomegalovirus DNAemia | Q71693376 |
| | Immune Parameters in a Longitudinal Study of a Very Old Population of Swedish People: A Comparison Between Survivors and Nonsurvivors | Q71799763 |
| | Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women | Q72353255 |
| | Transmission of cytomegalovirus infection through breast milk in term and preterm infants. The role of cell free milk whey and milk cells | Q73156688 |
| | HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children | Q73419672 |
| | Flow cytometric analysis of cytomegalovirus-specific cell-mediated immunity in the congenital infection | Q73851982 |
| | Transmission of cytomegalovirus to preterm infants through breast milk | Q74195690 |
| | Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study | Q77436737 |
| | Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children | Q81857127 |
| | Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART | Q82867167 |
| | Decreased risk of congenital cytomegalovirus infection in children born to HIV-1-infected mothers in the era of highly active antiretroviral therapy | Q83709481 |
| | Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation | Q87829625 |
| | Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS | Q33818170 |
| | Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis | Q33939861 |
| | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything | Q34022257 |
| | Immunity to HIV in Early Life | Q34033051 |
| | Early Antiretroviral Therapy and Mortality among HIV-Infected Infants | Q34175450 |
| | Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment | Q34315579 |
| | A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. | Q34413309 |
| | Cytomegalovirus blood viral load and hearing loss in young children with congenital infection | Q34549638 |
| | Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants | Q34734281 |
| | Plasma levels of soluble CD14 independently predict mortality in HIV infection | Q34764002 |
| | Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group | Q34792820 |
| | Mature CD8(+) T lymphocyte response to viral infection during fetal life | Q35019349 |
| | HIV type 1 and cytomegalovirus coinfection in the female genital tract | Q35056743 |
| | Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women | Q35087763 |
| | Working parents: the impact of day care and breast-feeding on cytomegalovirus infections in offspring | Q35111206 |
| | Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission | Q35127311 |
| | Effect of cytomegalovirus co-infection on normalization of selected T-cell subsets in children with perinatally acquired HIV infection treated with combination antiretroviral therapy | Q35203449 |
| | Cytomegalovirus Infection in Patients with AIDS | Q35226759 |
| | Valganciclovir for symptomatic congenital cytomegalovirus disease | Q35465712 |
| | Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals | Q35560718 |
| | Early acquisition of cytomegalovirus infection | Q35603960 |
| | The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers | Q35612521 |
| | Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia | Q35672554 |
| | Effect of cytomegalovirus infection on breastfeeding transmission of HIV and on the health of infants born to HIV-infected mothers | Q35825670 |
| | Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation | Q35857674 |
| | The March towards a Vaccine for Congenital CMV: Rationale and Models | Q35920807 |
| | Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy | Q35923609 |
| | Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda | Q35993475 |
| | Antiviral therapy of congenital cytomegalovirus infection | Q36026735 |
| | Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections | Q36185647 |
| | T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children | Q36222075 |
| | Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants | Q36276152 |
| | CMV as a cofactor enhancing progression of AIDS. | Q36368789 |
| | Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART). | Q36468518 |
| | Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcom | Q45747974 |
| | Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle | Q45752984 |
| | Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. | Q45765731 |
| | Cytomegalovirus infection in human immunodeficiency virus type 1-infected children | Q45767330 |
| | Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study | Q46293092 |
| | The effect of prenatal highly active antiretroviral therapy on the transmission of congenital and perinatal/early postnatal cytomegalovirus among HIV-infected and HIV-exposed infants | Q46363344 |
| | Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in The Gambia. | Q46873966 |
| | Antibody response to human cytomegalovirus (HCMV) glycoprotein B (gB) in AIDS patients with HCMV end-organ disease | Q47855216 |
| | Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. | Q50465721 |
| | Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. | Q50509889 |
| | The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life | Q36496904 |
| | Vertical Cytomegalovirus Transmission From HIV-Infected Women Randomized to Formula-Feed or Breastfeed Their Infants | Q36597761 |
| | The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women | Q36601953 |
| | Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. | Q36607261 |
| | Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy | Q36757599 |
| | Prospective Characterization of the Risk Factors for Transmission and Symptoms of Primary Human Herpesvirus Infections Among Ugandan Infants | Q37003029 |
| | Cytomegalovirus in the neonate: immune correlates of infection and protection | Q37140130 |
| | The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants | Q37336986 |
| | Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients | Q37377683 |
| | Acute cytomegalovirus infection in Kenyan HIV-infected infants | Q37386385 |
| | Compartmentalized cytomegalovirus replication and transmission in the setting of maternal HIV-1 infection | Q37528411 |
| | Postnatal cytomegalovirus exposure in infants of antiretroviral-treated and untreated HIV-infected mothers | Q37644893 |
| | Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed? | Q37996226 |
| | Cytomegalovirus, aging, and HIV: a perfect storm | Q38029533 |
| | Insights into B cells and HIV-specific B-cell responses in HIV-infected individuals | Q38114912 |
| | Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review | Q38125299 |
| | Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review. | Q38260298 |
| | Incidence of opportunistic and other infections in HIV-infected children in the HAART era. | Q38467275 |
| | Comparative Prevalence of Subclinical Cytomegalovirus and Herpes Simplex Virus Infections in the Genital and Urinary Tracts of Low-Income, Urban Women | Q39205668 |
| | High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa | Q39285513 |
| | Epidemiology and transmission of cytomegalovirus | Q39496031 |
| | Cervical Cytomegalovirus Excretion in Pregnant and Nonpregnant Women: Suppression in Early Gestation | Q39928623 |
| | Perinatal Cytomegalovirus Infection: Influence of Placentally Transferred Maternal Antibody | Q40152840 |
| | Maternal immunity and prevention of congenital cytomegalovirus infection | Q40604196 |
| | Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants. | Q40680033 |
| | Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants | Q40764424 |
| | Cytomegalovirus immediate early genes upregulate interleukin-6 gene expression | Q41117991 |
| | Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding | Q41584640 |
| | Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly | Q41754380 |
| | Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients | Q42202541 |
| | Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa | Q42227184 |
| | Impact of CMV therapy with valganciclovir on immune activation and the HIV viral load in semen and blood: an observational clinical study | Q42264931 |
| | CMV pneumonia in HIV-infected ventilated infants | Q42665244 |
| | Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy | Q42720721 |
| | Longitudinal analysis of human cytomegalovirus glycoprotein B (gB)-specific and neutralizing antibodies in AIDS patients either with or without cytomegalovirus end-organ disease | Q43446936 |
| | Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy | Q43564797 |
| | Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy | Q43774416 |
| | No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study | Q43971598 |
| | Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity | Q44110286 |
| | Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial | Q44547726 |
| | Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss | Q45443662 |
| | Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients | Q45735728 |
| | Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infected women | Q45746611 |
| P433 | issue | 4 | |
| P304 | page(s) | 208-214 | |
| P577 | publication date | 2016-10-05 | |
| P1433 | published in | Journal of virus eradication | Q27726372 |
| P1476 | title | Cytomegalovirus and paediatric HIV infection | |
| P478 | volume | 2 | |